Back to Trades
Boston Megan
Chief Financial OfficerDirectorCIK 0001808923
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 1
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2025
Across 1 filing between 2025, Boston Megan, Chief Financial Officer, Director, has disclosed $2.7M in transactions — all concentrated in Benitec Biopharma Inc. (BNTC). Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
1 loaded
| Nov 20 | BNTC Benitec Biopharma Inc. | Boston Megan | Chief Financial Officer, Director | Award | $2.7M |
1 filing